KEVIN NASH: Open Payments
NPI 1265787402 · CANTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,001 in 13 payments from 7 companies in 2025. Trend: 2023 $947 · 2024 $1,261 · 2025 $1,001
Food & beverage: $1,001
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $312 |
| Corcept Therapeutics | 4 | $256 |
| ABBVIE INC. | 1 | $125 |
| Gilead Sciences, Inc. | 1 | $122 |
| Phathom Pharmaceuticals, Inc. | 1 | $107 |
| Abbott Laboratories | 1 | $52 |
| Stemline Therapeutics Inc. | 1 | $28 |
Products named: Korlym, Ozempic, MAVYRET, Epclusa, Wegovy, VOQUEZNA, FREESTYLE LIBRE 3, ELZONRIS.
Industry payments across OH — which companies pay providers there.
